Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation for relieving wheezing in children
ChiCTR2300077620Phase 4Completed
- Sponsor
- Shunde Women and Children's Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Wheezing-associated respiratory infection (WARI), acute bronchitis and pneumonia comparing Ambroxol Hydrochloride Solution arm with Saline placebo arm (2 arms). Primary endpoints: Wheezy phlegm sound and Wheezing severity. Started Jul 2022; status: completed.
02
Drugs
ambroxol
03
Conditions
Wheezing-associated respiratory infection (WARI)acute bronchitispneumonia
Beyond the preview
Go deeper on ChiCTR2300077620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077620.